The PPI results showed that the target genes of IL6, IL10, TNF, IL1B, CXCL8, IL1A, CCL2, CSF2, CSF3, and CCL5 might be the core targets of OA-enhanced aspirin therapy for CRC. The gene discussed is IL1B; the disease is colorectal carcinoma.